3.0.0.0 Glu­cose As­sess­ment

For many peo­ple with di­a­betes, glu­cose mon­i­tor­ing is key for the achieve­ment of glycemic tar­gets. Major clin­i­cal tri­als of in­sulin-treat­ed pa­tients have in­clud­ed SMBG as part of mul­ti­fac­to­ri­al in­ter­ven­tions to demon­strate the benefit of in­ten­sive glycemic con­trol on di­a­betes com­pli­ca­tions (16). SMBG is thus an in­te­gral com­po­nent of ef­fec­tive ther­a­py of pa­tients tak­ing in­sulin. In re­cent years, CGM has emerged as a com­ple­men­tary method for the as­sess­ment of glu­cose lev­els. Glu­cose mon­i­tor­ing al­lows pa­tients to eval­u­ate their in­di­vid­u­al re­sponse to ther­a­py and as­sess whether glycemic tar­gets are being safe­ly achieved. In­te­grat­ing re­sults into di­a­betes man­age­ment can be a use­ful tool for guid­ing med­i­cal nu­tri­tion ther­a­py and phys­i­cal ac­tiv­i­ty, pre­vent­ing hy­po­glycemia, and ad­just­ing med­i­ca­tions (par­tic­u­lar­ly pran­di­al in­sulin doses). The pa­tient’s specific needs and goals should dic­tate SMBG fre­quen­cy and tim­ing or the con­sid­er­a­tion of CGM use. Please refer to Sec­tion 7 “Di­a­betes Tech­nol­o­gy” for a fuller dis­cus­sion of the use of SMBG and CGM.